Sonnet Biotherapeutics Holdings

SONN · NASDAQ

$51.02+$51.02 (+0.00%)TodayMarket closed ·
Prev close $0.00

Latest news

  • Press releaseGlobe Newswire

    Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseGlobe Newswire

    Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HBI, BFIN, PBBK, SONN on Behalf of Shareholders

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Sonnet Releases Virtual Investor "What This Means" Segment

  • Press releaseGlobe Newswire

    Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseGlobe Newswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders

  • Press releasePRNewswire

    SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: SONN, SKX, FCCO, and SGBG

  • NewsShivdeep Dhaliwal

    Palantir, The Trade Desk, Tilray, Sonnet Biotherapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

  • Press releaseGlobe Newswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

  • NewsAvi Kapoor

    Crude Oil Moves Lower; Daré Bioscience Shares Jump

  • NewsVandana Singh

    Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday?

  • NewsAvi Kapoor

    US Stocks Edge Lower; Fastenal Posts Upbeat Earnings

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, SONN on Behalf of Shareholders

  • Press releaseBusiness Wire

    SONN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sonnet BioTherapeutics, Inc. Is Fair to Shareholders

  • News

    Market-Moving News for July 14th

  • Press releaseGlobe Newswire

    Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy

  • NewsRishabh Mishra

    US Stocks Likely To Open Lower After A Week Of Records: Tesla In Focus As Elon Musk Announces America Party

  • NewsMohd Haider

    Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit

  • Press releaseGlobe Newswire

    Sonnet Releases Virtual Investor "What This Means" Segment

  • Press releaseGlobe Newswire

    Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose

  • Press releaseGlobe Newswire

    Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

  • NewsAvi Kapoor

    Gold Down Over 2%; CVS Health Shares Jump After Q3 Results

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Dow Jumps Over 1,200 Points; Donald Trump Wins White House

  • NewsAvi Kapoor

    Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views

  • Press releaseGlobe Newswire

    Sonnet BioTherapeutics Announces Launch of CEO Corner Platform

  • NewsAvi Kapoor

    Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket

  • NewsHenry Khederian

    Why Sonnet BioTherapeutics (SONN) Shares Are Down 19% Today

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.